8Q4L

GBP1 bound by 14-3-3sigma


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 5.12 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection.

Fisch, D.Pfleiderer, M.M.Anastasakou, E.Mackie, G.M.Wendt, F.Liu, X.Clough, B.Lara-Reyna, S.Encheva, V.Snijders, A.P.Bando, H.Yamamoto, M.Beggs, A.D.Mercer, J.Shenoy, A.R.Wollscheid, B.Maslowski, K.M.Galej, W.P.Frickel, E.M.

(2023) Science 382: eadg2253-eadg2253

  • DOI: https://doi.org/10.1126/science.adg2253
  • Primary Citation of Related Structures:  
    8Q4L

  • PubMed Abstract: 

    Disruption of cellular activities by pathogen virulence factors can trigger innate immune responses. Interferon-γ (IFN-γ)-inducible antimicrobial factors, such as the guanylate binding proteins (GBPs), promote cell-intrinsic defense by attacking intracellular pathogens and by inducing programmed cell death. Working in human macrophages, we discovered that GBP1 expression in the absence of IFN-γ killed the cells and induced Golgi fragmentation. IFN-γ exposure improved macrophage survival through the activity of the kinase PIM1. PIM1 phosphorylated GBP1, leading to its sequestration by 14-3-3σ, which thereby prevented GBP1 membrane association. During Toxoplasma gondii infection, the virulence protein TgIST interfered with IFN-γ signaling and depleted PIM1, thereby increasing GBP1 activity. Although infected cells can restrain pathogens in a GBP1-dependent manner, this mechanism can protect uninfected bystander cells. Thus, PIM1 can provide a bait for pathogen virulence factors, guarding the integrity of IFN-γ signaling.


  • Organizational Affiliation

    Host-Toxoplasma Interaction Laboratory, The Francis Crick Institute, London, UK.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Guanylate-binding protein 1577Homo sapiensMutation(s): 0 
Gene Names: GBP1
UniProt & NIH Common Fund Data Resources
Find proteins for P32455 (Homo sapiens)
Explore P32455 
Go to UniProtKB:  P32455
PHAROS:  P32455
GTEx:  ENSG00000117228 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP32455
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 2
MoleculeChains Sequence LengthOrganismDetailsImage
14-3-3 protein sigma
B, C
231Homo sapiensMutation(s): 0 
Gene Names: SFN
UniProt & NIH Common Fund Data Resources
Find proteins for P31947 (Homo sapiens)
Explore P31947 
Go to UniProtKB:  P31947
PHAROS:  P31947
GTEx:  ENSG00000175793 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP31947
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 5.12 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Boehringer Ingelheim Fonds (BIF)Germany--
Human Frontier Science Program (HFSP)FranceLT0006/2022-L
European Molecular Biology Organization (EMBO)European UnionALTF 491-2022
Wellcome TrustUnited Kingdom217202/Z/19/Z
Medical Research Council (MRC, United Kingdom)United KingdomMR/V030930/1
Medical Research Council (MRC, United Kingdom)United KingdomMR/T029323/1
Wellcome TrustUnited KingdomFC001076
Medical Research Council (MRC, United Kingdom)United KingdomFC001076
Cancer Research UKUnited KingdomFC001076

Revision History  (Full details and data files)

  • Version 1.0: 2023-10-11
    Type: Initial release
  • Version 1.1: 2023-10-18
    Changes: Database references